UBS Group’s Jupiter Wellness Acquisition Corp. Class A Common Stock JWAC Stock Holding History

UBS Group’s Portfolio JWAC Stock Details JWAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$2.11K	–	10304
2023 Q1	$2.11K	Sell	200 -1,475	-88%	-$15.3K	﹤0.01%	8577
2022 Q4	$17.5K	Sell	1,675 -11	-0.7%	-$111	﹤0.01%	7826
2022 Q3	$17K	Hold	1,686	–	–	﹤0.01%	7652
2022 Q2	$17K	Hold	1,686	–	–	﹤0.01%	7152
2022 Q1	$17K	Buy	+1,686	New	+$16.6K	﹤0.01%	7703

UBS Group's JWAC Position: Q2 2023 in Review

UBS Group sold out of Jupiter Wellness Acquisition Corp. Class A Common Stock (JWAC) in Q2 2023, closing a stake of 200 shares — an estimated $2.11K sold.

UBS Group first reported a position in JWAC in Q1 2022 and held it in 5 quarters. The position peaked at $17.5K in Q4 2022. 0 funds tracked by Wall St. Rank hold JWAC as of Q2 2023.

UBS Group reported no remaining Jupiter Wellness Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
UBS Group sold 200 Jupiter Wellness Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.11K.
UBS Group first reported a position in Jupiter Wellness Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
UBS Group's Jupiter Wellness Acquisition Corp. Class A Common Stock position peaked at $17.5K in Q4 2022.
0 funds tracked by Wall St. Rank held Jupiter Wellness Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.